FDA Inspection
SterRx, LLCSterRx, LLC – FDA Inspection, Mar 17, 2017
Record Details
This FDA Inspection record concerns SterRx, LLC, with an inspection on March 17, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 81ed2d81-bb72-4365-bcc0-842ca18b8695
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1007560
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.166(a)Results not used for expiration dates, storage cond.
- FDCA 503B(a)(10)Drug product label, outsourcer facility
Full citation text and observation details available on the Dashboard.
Other FDA inspections of SterRx, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 28, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 4, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 7, 2019 | Not classified | New York District Office |
Other documents for SterRx, LLC
- FDA Inspection 1209342 - 2023-06-28
- FDA Inspection 1156750 - 2021-11-04
- FDA Inspection 1097893 - 2019-06-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.